SavedAdd your journal

Journals / Journal of Clinical and Experimental Investigations / 2026 / Cilt: 3 Sayı: 3

Long term neurodevelopmental outcome of preterm infants with periventricularintraventricular hemorrhage

Periventriküler-intraventriküler kanaması bulunan prematür bebeklerin uzun dönem nörogelişimsel sonuçları

Erhan Bayram
Meral Torun Bayram
Yasemin Topcu
Semra Hiz
Ertan Kayserili
Pages
326–330
Publication Date
2012-09-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

All premature infants should be evaluated by Denver II Developmental Screening Test in early childhood period of life.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To determine the neurodevelopmental morbidity of preterm infants with periventricular- intraventricular hemorrhage, at the age of 4.
📊
Key Findings & Data:Materials and methods: The patients at the age of 4 were evaluated through neurologic examination and motor assessment by a pediatric neurologist and Denver II Developmental Screening Test by a psychologist.
💡
Conclusion & Impact:All premature infants should be evaluated by Denver II Developmental Screening Test in early childhood period of life.
🔬Design:Makale
📍Scope:Comprehensive Sample
⚙️Variables:Prematürite · periventriküler kanama · İntraventriküler kanama

Abstract

Objectives: To determine the neurodevelopmental morbidity of preterm infants with periventricular- intraventricular hemorrhage, at the age of 4. Materials and methods: The patients at the age of 4 were evaluated through neurologic examination and motor assessment by a pediatric neurologist and Denver II Developmental Screening Test by a psychologist. The results were compared with Denver II Developmental Screening Test results which had been made at 3-6 and 6-12 months. Results: Patients with grade ІІІ-ІV Periventricular-Intraventricular Hemorrhage had significantly lower Denver II Developmental Screening Test results at the age of 4, compared with grade І-ІІ Periventricular-Intraventricular Hemorrhage group. Similarly, ≤ 32 weeks patients had significantly lower Denver II Developmental Screening Test at the age of 4 when compared with > 32 weeks patients. Conclusions: Children who were born ≤ 32 gestational weeks and/or patients with grade ІІІ-ІV periventricular-intraventricular Hemorrhage have an increased risk of neurologic impairment. All premature infants should be evaluated by Denver II Developmental Screening Test in early childhood period of life.

Özet

Amaç: Periventriküler-intraventriküler kanaması bulunan prematüre bebeklerin, 4 yaş, nörogelişimsel morbiditelerinin belirlenmesi. Gereç ve yöntem: Dört yaşındaki hastalar, nörolojik muayene ve motor değerlendirmeleri için bir çocuk nöroloğu tarafından ve Denver II Gelişimsel Tarama Testleri için bir psikolog tarafından değerlendirildi. Sonuçlar, 3-6 ay ve 6-12. ayda yapılan Denver II Gelişimsel Tarama Testleri sonuçları ile karşılaştırıldı. Bulgular: Evre III-IV periventriküler-intraventriküler kanaması bulunan olguların 4 yaşındaki Denver II Gelişimsel Tarama Testleri, evre I-II periventriküler-intraventriküler kanaması bulunan grupla karşılaştırıldığında belirgin olarak geri idi. Aynı şekilde, ≤ 32 hafta doğan olgular > 32 hafta doğanlarla karşılaştırıldığında, 4 yaşındaki Denver II Gelişimsel Tarama Testleri belirgin olarak geri saptandı. Sonuç: Sonuç olarak, ≤ 32 gestasyonel haftada doğan ve/veya evre III-IV periventriküler-intraventriküler kanaması olan olgularda nörolojik etkilenme riski artmaktadır. Bütün prematüre bebkler, erken çocukluk döneminde Denver II Gelişimsel Tarama Testi ile değerlendirilmelidir.

🔖

Cite This Article

Bayram, E., Bayram, M. T., Topcu, Y., Hiz, S., Kayserili, E. (2012). Long term neurodevelopmental outcome of preterm infants with periventricularintraventricular hemorrhage. Journal of Clinical and Experimental Investigations, Cilt: 3 Sayı: 3, 326–330. https://doi.org/10.5799/ahinjs.01.2012.03.0172

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR. Neurologic and developmental disability after ex- tremely preterm birth: EPICure Study Group. N Engl J Med 2000;343(6):378-84.
  2. Arpino C, Compagnone E, Montanaro ML, et al. Pre- term birth and neurodevelopmental outcome: a re- view. Childs Nerv Syst 2010;26(9):1139-49.
  3. Hamrick SEG, Miller SP, Leonard C, et al. Trends in se- vere brain injury and neurodevelopmental outcome in premature newborn infants: the role of cystic periven- tricular leukomalacia. J Pediatr 2004;145(5):593-9.
  4. Simpson J M, Evans N, Gibberd R W, Heuchan AM, Henderson-Smart DJ. Analysing differences in clini- cal outcomes between hospitals. Qual Saf Health Car. 2003;12(4):257-62.
  5. Volpe JJ. Neurology of the Newborn. 4th ed. Philadel- phia, PA: Saunders WB; 2001.
  6. Perlman JM, Volpe JJ. Intraventricular hemor- rhage in extremely small premature infants. AJDC 1986;140(11):122-4.
  7. Volpe JJ. Intracranial hemorrhage: germinal matrix-in- traventricular hemorrhage of the premature infant. In: Neurology of the Newborn. 4th ed. Philadelphia: WB Saunders; 1995:462- 9.
  8. Schmidt B, Davis P, Moddemann D, et al. Long-term effects of indomethacin prophylaxis in extremely-low- birth-weight infants. N Engl J Med 2001;344(26):1966 -72.
  9. Brévaut-Malaty V, Busuttil M, Einaudi MA, Monnier AS, D’Ercole C, Gire C. Longitudinal follow-up of a cohort of 350 singleton infants born at less than 32 weeks of amenorrhea: neurocognitive screening, academic outcome, and perinatal factors. Eur J Obstet Gynecol Reprod Biol 2010;150(1):13-8.
  10. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birthweights less than 1500 g. J Pediatr 1978;92(4):529-34.
  11. Lemons JA, Bauer CR, Oh W, et al. Very-low-birth- weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pe- diatrics 2001;107(1):1-8.
  12. Engle WA, Tomashek KM, Wallman C, the Committee on Fetus and Newborn. Late-preterm infants: a popu- lation at risk. Pediatrics 2007;120(6):1390-401.
  13. Glascoe FP, Byrne KE, Ashford LG, Johnson KL, Chang B, Strickland B. Accuracy of the Denver-II in developmental screening. Pediatrics 1992;89(6 Pt 2):1221-5.
  14. Bayram M, Kayserili E, Agin H, Bayram E, Unalp A. Evaluation of Short-Term Neurodevelopmental Out- comes in the Premature Patients with Periventricu- lar-Intraventricular Hemorrhage. J. Ped Neurology 2008;6(4):1-2.
  15. Piekkala P, Kero P, Sillanpaa M, Erkkola R. The devel- opmental profile and outcome of 325 unselected pre- term infants up to two years of age. Neuropediatrics 1988;19(1):33-40.
  16. Volpe JJ. Intracranial hemorrhage: Germinal matrix- intraventricular hemorrhage of the premature infant. In: Neurology of the Newborn 4th ed. Philadelphia: Saunders WB; 1995:437- 54.
  17. Patra K, Wilson-Costello D, Taylor HG, Mercuri-Minich N, Hack M. Grades I-II intraventricular hemorrhage in extremely low birth weight infants: effects on neurode- velopment. J Pediatr 2006;149(2):169-73.
  18. Childs AM, Cornette L, Ramenghi LA, et al. Magnetic resonance and cranial ultrasound characteristics of periventricular white matter abnormalities in newborn infants. Clin Radiol 2001;56(8):647-55.